NCT01484652 - Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension | Biotech Hunter

Enrollment

329

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions

Pain, PostoperativeBunion

Interventions

DRUG

COV795

2 tablets taken every 12 hours

DRUG

Placebo

2 tablets taken every 12 hours

Trial Locations (5)

Chesapeake Research Group, LLC, Pasadena

Endeavor Clinical Trials, PA, San Antonio

Jean Brown Research, Inc., Salt Lake City

Lotus Clinical Research, LLC, Pasadena

Trovare Clinical Research, Inc., Bakersfield